Trial in Brazil finds 11% of high-risk patients on fluvoxamine needed hospitalization, compared with 16% who were given the placebo; course of the treatment costs just $4

Bennett reportedly makes announcement to coronavirus cabinet; if cleared, molnupiravir would be 1st pill shown to treat coronavirus patients, a potentially major advance

Drug to be given to those exposed to infection in a bid to stop disease from progressing to severe, drug is first oral antiviral specifically designed for coronavirus

People with two doses see three-fold reduction in antibodies that fight variant compared to other types, but are still safe, researchers find

Oral treatment seeks to block enzyme the coronavirus needs in order to replicate in human cells

Number larger than population of Chicago or Kyiv, Ukraine; meanwhile crisis is deepening in places such as Brazil, India and France

R-value shows virus spread nearly at point of expansion again; health minister implores Jerusalemites to 'leave the parties until after the coronavirus'

Team suggests reassessing plans to further ease restrictions; new mutation on rise in NYC shares characteristics with South African strain, may curb vaccine effectiveness

Shaare Zedek hospital finds 94% still report symptoms three months on, notably shortness of breath, but most symptoms disappear within six months

In early 2020, donors recruited by the Covid Plasma Initiative supplied 50% of the nation's plasma, also demonstrating the treatment's efficacy and paving the way to widespread use